Loading: 100%
Egalet Corp logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 154 (as per Q3 2016)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker EGLTno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,02,55,07,510,0
datesClosing price (adj.)
13.10.20171.14
11.10.20171.18
04.10.20171.22
27.09.20171.29
20.09.20171.40
13.09.20171.47
06.09.20171.28
30.08.20171.17
23.08.20171.07
16.08.20171.10
09.08.20171.15
02.08.20171.16
26.07.20171.48
19.07.20171.42
12.07.20171.36
05.07.20172.54
27.06.20172.45
20.06.20172.36
13.06.20172.63
06.06.20172.75
30.05.20172.28
23.05.20172.80
16.05.20172.91
09.05.20172.96
02.05.20173.34
25.04.20174.23
18.04.20174.39
11.04.20174.38
04.04.20174.65
28.03.20174.84
21.03.20174.62
14.03.20174.58
07.03.20174.62
28.02.20174.94
21.02.20174.97
14.02.20174.88
07.02.20174.57
31.01.20174.89
24.01.20175.32
17.01.20175.34
10.01.20176.52
03.01.20177.96
27.12.20168.61
19.12.20168.30
12.12.20168.13
05.12.20167.73
28.11.20166.98
21.11.20168.07
14.11.20167.77
07.11.20165.58
31.10.20165.61
24.10.20167.02
17.10.20167.82
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
1.14n/a
Market Capitalisation
in million USD
29n/a
Enterprise Value
in million USD
10n/a
Common Shares Outstanding
as per Sep 30, 2016
25,189,125n/a
Preferred Shares Outstanding
as per Sep 30, 2016
n/a
Average Basic Shares Outstanding
TTM
24,476,258n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Egalet Corp is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize proprietary, abuse-deterrent oral products for the treatment of pain and in other indications.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 30n/a
Gross Profit 30n/a
Operating Income -69n/a
EBITDA -65n/a
Net Profit -76n/a
Balance Sheet
Cash and Cash Equivalents 101n/a
Receivables 4n/a
Total Current Assets 110n/a
PP&E 14n/a
Total Assets 134n/a
Accounts Payable 6n/a
Current Debt 0n/a
Total Current Liabilities 25n/a
Long-Term Debt 82n/a
Total Liabilities 109n/a
Total Equity 26n/a
Cash Flow
Depreciation & Amortisation 3n/a
Change in Working Capital -13n/a
Operating Cash Flow -76n/a
Net Change in PP&E and Intangibles 4n/a
Investing Cash Flow 23n/a
Dividends Paid 0n/a
Financing Cash Flow 22n/a
Total Change in Cash -31n/a
Free Cash Flow -74n/a
Profitability Ratios
Gross Margin 100.0%n/a
Operating Margin -228.1%n/a
Net Profit Margin -251.8%n/a
Return on Equity -297.6%n/a
Return on Assets -56.7%n/a
Per Share Figures
Basic EPS -3.11n/a
Diluted EPS n/a
Sales per Share 1.23n/a
Book Value per Share 1.04n/a
FCF per Share -3.01n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -0.37n/a
Price to Sales Ratio 0.92n/a
Price to Book Value 1.09n/a
Price to Free Cash Flow -0.38n/a
Valuation Metrics
EV/EBITDA -0.15n/a
EV/Sales 0.32n/a
Book to Market Value 0.89n/a
Other Ratios
Current Ratio 435.7%n/a
Liabilities to Equity Ratio 424.6%n/a
Debt to Assets Ratio 61.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Revenue
1
0
2
23
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
0
0
0
0
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
1
0
2
23
Other Operating Income
0
0
0
0
Operating Expenses
-6
-11
-39
-75
Selling, General & Administrative
-2
-5
-17
-46
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
-4
-6
-22
-27
Depreciation & Amortization
0
0
0
-2
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
-5
-11
-37
-52
Non-Operating Income (Loss)
0
-9
-6
-6
Interest Expense, net
0
-9
-7
-7
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
Other Non-Operating Income (Loss)
0
0
1
1
Pretax Income (Loss), Adjusted
-5
-20
-43
-59
Abnormal Gains (Losses)
0
0
0
0
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
-5
-20
-43
-59
Income Tax (Expense) Benefit, net
0
0
0
1
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
-5
-20
-43
-58
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
-5
-20
-43
-58
Minority Interest
0
0
0
0
Net Income
-5
-20
-43
-58
Preferred Dividends
0
0
0
0
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
-5
-20
-43
-58
Remarks
restated on Mar 16, 2015 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
16
53
146
Cash & Cash Equivalents
n/a
16
53
47
Short Term Investments
n/a
0
0
99
Accounts & Notes Receivable
n/a
0
0
0
Accounts Receivable, Net
n/a
0
0
0
Notes Receivable, Net
n/a
0
0
0
Unbilled Revenues
n/a
0
0
0
Inventories
n/a
0
0
2
Raw Materials
n/a
0
0
0
Work In Process
n/a
0
0
0
Finished Goods
n/a
0
0
0
Other Inventory
n/a
0
0
0
Other Short Term Assets
n/a
2
2
2
Prepaid Expenses
n/a
2
1
1
Derivative & Hedging Assets
n/a
0
0
0
Assets Held-for-Sale
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Income Taxes Receivable
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Miscellaneous Short Term Assets
n/a
0
2
1
Total Current Assets
n/a
18
55
150
Property, Plant & Equipment, Net
n/a
2
4
8
Property, Plant & Equipment
n/a
0
0
0
Accumulated Depreciation
n/a
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
Long Term Investments
n/a
0
0
0
Long Term Marketable Securities
n/a
0
0
0
Long Term Receivables
n/a
0
0
0
Other Long Term Assets
n/a
0
1
14
Intangible Assets
n/a
0
0
10
Goodwill
n/a
0
0
0
Other Intangible Assets
n/a
0
0
0
Prepaid Expense
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
Prepaid Pension Costs
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Investments in Affiliates
n/a
0
0
0
Miscellaneous Long Term Assets
n/a
0
1
4
Total Noncurrent Assets
n/a
3
5
22
Total Assets
n/a
20
61
172
Liabilities and owners' equity
Payables & Accruals
n/a
3 2801000
7 6763000
15 15033000
Accounts Payable
n/a
1 1046000
4 4209000
7 7417000
Accrued Taxes
n/a
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
Other Payables & Accruals
n/a
2 1755000
3 2554000
8 7616000
Short Term Debt
n/a
0 0
0 0
3 3320000
Short Term Borrowings
n/a
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
Other Short Term Liabilities
n/a
18 17821000
1 666000
10 10311000
Deferred Revenue
n/a
1 557000
1 588000
10 10128000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
17 17264000
0 78000
0 183000
Total Current Liabilities
n/a
21 20622000
7 7429000
29 28664000
Long Term Debt
n/a
0 0
0 0
52 52442000
Long Term Borrowings
n/a
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
Other Long Term Liabilities
n/a
25 24571000
9 8880000
2 2088000
Accrued Liabilities
n/a
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
10 9592000
9 8855000
0 0
Deferred Tax Liabilities
n/a
0 22000
0 25000
1 1084000
Derivatives & Hedging
n/a
0 0
0 0
1 656000
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
15 14957000
0 0
0 348000
Total Noncurrent Liabilities
n/a
25 24571000
9 8880000
55 54530000
Total Liabilities
n/a
45 45193000
16 16309000
83 83194000
Preferred Equity
n/a
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
7 7444000
121 121045000
224 223809000
Common Stock
n/a
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
Retained Earnings
n/a
-33 -33399000
-77 -76613000
-135 -134546000
Other Equity
n/a
1 1125000
0 -171000
0 -41000
Equity Before Minority Interest
n/a
-25 -24830000
44 44261000
89 89222000
Minority Interest
n/a
0 0
0 0
0 0
Total Equity
n/a
-25 -24830000
44 44261000
89 89222000
Total Liabilities & Equity
n/a
20 20363000
61 60570000
172 172416000
Remarks restated on n/a restated on Mar 16, 2015 n/a restated on Mar 11, 2016 n/a restated on Nov 8, 2016 n/a
Cash Flow StatementCF data quality: 93% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Net Income/Starting Line
-5
-20
-43
-58
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
0
0
1
3
Non-Cash Items
0
8
16
9
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
0
11
2
7
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
-5
0
-25
-39
Change in Fixed Assets & Intangibles
0
-2
-3
-3
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
0
0
0
-110
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
0
0
-1
-7
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
0
-2
-4
-120
Dividends Paid
0
0
0
0
Cash From (Repayment of) Debt
0
15
0
71
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
8
0
67
81
Increase in Capital Stock
8
0
67
81
Decrease in Capital Stock
0
0
0
0
Other Financing Activities
0
-1
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
8
14
67
152
Net Cash Before Disc. Operations and FX
2
11
38
-6
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
2
11
38
-6
Effect of Foreign Exchange Rates
0
1
-1
0
Net Changes in Cash
2
12
37
-6
Remarks
restated on Mar 16, 2015 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo